| Structure | Chemical Name | CAS | MF |
|
Fmoc-β-Ala-Glu(OtBu)-OH
|
2411592-43-1
|
C27H32N2O7
|
|
Methyl 2-amino-2-(3-bromo-4-chlorophenyl)acetate hydrochloride
|
2411634-43-8
|
C9H10BrCl2NO2
|
|
1-amino-4,5-dihydro-1H-benzo[d]azepin-2(3H)-one hydrochloride
|
2411634-46-1
|
C10H13ClN2O
|
|
3-(4-chlorophenyl)piperazine-2,5-dione
|
2411634-61-0
|
C10H9ClN2O2
|
|
Isoquinoline, 6-bromo-1-chloro-8-fluoro-
|
2411635-02-2
|
C9H4BrClFN
|
|
Pyrrolidine, 2-(2,5-dichlorophenyl)-, hydrochloride (1:1)
|
2411635-26-0
|
C10H11Cl2N.ClH
|
|
2H-Cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1(6H)-one, 7,8-dihydro-7,7-dimethyl-
|
2411635-50-0
|
C12H14N2O
|
|
2-Amino-2-(2,6-difluorophenyl)acetic acid hydrochloride
|
2411635-69-1
|
C8H8ClF2NO2
|
|
2-(aminomethyl)-5-(4-methylthiazol-5-yl)phenol hydrochloride
|
2411635-80-6
|
C11H13ClN2OS
|
|
H-pyrazolo[1,5-a]pyridin-2-amine hydrochloride
|
2411637-38-0
|
C7H8ClN3
|
|
3-(3,4-difluorophenyl)oxetan-3-amine hydrochloride
|
2411637-48-2
|
C9H10ClF2NO
|
|
4- (1-hydroxy-1-methylethyl) -2-propyl -1H-imidazole-5- acetyl
|
2411637-68-6
|
C11H18N2O2
|
|
methyl 3-(tert-butoxymethyl)-1H-pyrazole-4-carboxylate
|
2411637-71-1
|
C10H16N2O3
|
|
2-Amino-2-(2,5-dichlorophenyl)ethanol hydrochloride
|
2411638-49-6
|
C8H10Cl3NO
|
|
3,3-dimethylindolin-4-amine hydrochloride
|
2411639-80-8
|
C10H15ClN2
|
|
1H-Inden-1-one, 6-bromo-2,3-dihydro-5-(trifluoromethyl)-
|
2411641-16-0
|
C10H6BrF3O
|
|
2-Thiophenecarboxaldehyde, 5-[5,7-bis(2-ethylhexyl)-4,8-dioxo-3-(2-thienyl)-4H,8H-benzo[1,2-c:4,5-c′]dithien-1-yl]-
|
2411657-11-7
|
C35H40O3S4
|
|
Hamaline
|
2411677-02-4
|
C20H19ClN2O
|
|
Thalidomide-O-PEG4-Boc
|
2411681-87-1
|
C28H38N2O11
|
|
Thalidomide-O-PEG4-NHS ester
|
2411681-88-2
|
C28H33N3O13
|
|
Thalidomide-O-amido-PEG4-azide
|
2411681-89-3
|
C25H32N6O10
|
|
Thalidomide-O-amido-PEG4-propargyl
|
2411681-90-6
|
C26H30N2O11
|
|
IHIC-2F
|
2411694-30-7
|
|
|
IHIC-2Me
|
2411694-32-9
|
|
|
EZM0414
|
2411748-50-8
|
C22H29FN4O2
|
|
1H-Indole-2-carboxamide, 4-fluoro-7-methyl-N-[(1R,3S)-3-[(3S)-3-[methyl(methylsulfonyl)amino]-1-pyrrolidinyl]cyclohexyl]-, rel-
|
2411757-44-1
|
C22H31FN4O3S
|
|
2-Pyridinamine, 6-bromo-N,N-bis[(4-methoxyphenyl)methyl]-4-methyl-5-(trifluoromethyl)-
|
2411793-14-9
|
C23H22BrF3N2O2
|
|
2-Pyridinamine, 6-chloro-N,N-bis[(4-methoxyphenyl)methyl]-4-methyl-5-(trifluoromethyl)-
|
2411793-22-9
|
C23H22ClF3N2O2
|
|
Benzaldehyde, 4,4',4'',4'''-(1,6-dihydro-1,3,6,8-pyrenetetrayl)tetrakis-
|
2411859-36-2
|
C44H28O4
|
|
L-Tryptophan, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-4-methyl-
|
2411871-30-0
|
C27H24N2O4
|
|
[4-(1-Methylpiperidin-4-yl)phenyl]boronic acid
|
2411875-80-2
|
C12H18BNO2
|
|
2-[3-(1,1-dimethyl ethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxyborane-2-yl) phenyl]-4-phenyl-pyridine
|
2411987-38-5
|
C27H32BNO2
|
|
Sepiumol A
|
2411999-52-3
|
C24H24O7
|
|
Sepiumol E
|
2412027-09-7
|
C23H24O6
|
|
5-[[2-(2-aminoethoxy)ethyl]amino]-2-(2,6-dioxo-3-piperidinyl)-1H-Isoindole-1,3(2H)-dione,
|
2412056-16-5
|
C17H20N4O5
|
|
(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)glycine
|
2412056-27-8
|
C15H13N3O6
|
|
3-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)amino)propanoic acid
|
2412056-29-0
|
C16H15N3O6
|
|
Pentanoic acid, 5-[[2-(2,6-dioxo-3-piperidinyl)-
2,3-dihydro-1,3-dioxo-1H-isoindol-5-yl]amino]-
|
2412056-33-6
|
C18H19N3O6
|
|
5-[(3-aminopropyl)amino]-2-(2,6-dioxo-3-piperidinyl)-1H-Isoindole-1,3(2H)-dione,
|
2412056-37-0
|
C16H18N4O4
|
|
5-[(7-aminobutyl)amino]-2-(2,6-dioxo-3-piperidinyl)-1H-Isoindole-1,3(2H)-dione,
|
2412056-40-5
|
C20H26N4O4
|
|
Imidazo[1,2-a]pyrazin-3(7H)-one, 6-(3-amino-2-fluorophenyl)-8-[(2-fluorophenyl)methyl]-2-(2-furanylmethyl)-
|
2412089-96-2
|
C24H18F2N4O2
|
|
2,4-di(pyridin-2-yl)-6-(pyridin-3-yl)pyrimidine
|
2412116-10-8
|
C19H13N5
|
|
2,4-di(pyridin-2-yl)-6-(pyridin-4-yl)pyrimidine
|
2412116-11-9
|
C19H13N5
|
|
Sepiumol C
|
2412138-09-9
|
C24H24O7
|
|
2-Propenamide, N-[5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]-2-[methyl[2-(methylamino)ethyl]amino]-6-(2,2,2-trifluoroethoxy)-3-pyridinyl]-
|
2412155-74-7
|
C27H29F3N8O2
|
|
L-Glutamic acid, N2-acetyl-L-arginyl-L-leucyl-L-tyrosyl-
|
2412172-33-7
|
C28H43N7O9
|
|
Acetamide, N-[4-(6-chloro-2-quinoxalinyl)phenyl]-
|
2412270-22-3
|
C16H12ClN3O
|
|
Cyclopentanecarboxylic acid, 3-[(1S)-1-amino-2-ethylbutyl]-4-[(aminoiminomethyl)amino]-2-hydroxy-, (1S,2S,3S,4R)-
|
2412376-06-6
|
C13H26N4O3
|
|
Spiro[9H-fluorene-9,2'-tricyclo[3.3.1.13,7]decane], 3-chloro-
|
2412392-50-6
|
C22H21Cl
|
|
1,3,5-Triazine, 2-[1,1'-biphenyl]-2-yl-4-[1,1'-biphenyl]-4-yl-6-(3-chlorophenyl)-
|
2412445-74-8
|
C33H22ClN3
|
|
Pregna-1,4,17(20)-trien-21-oic acid, 9-fluoro-11-hydroxy-16-methyl-3-oxo-, (11β,16β,17E)-
|
2412496-00-3
|
C22H27FO4
|
|
11H-?Benzo[b]?fluorene, 2-?chloro-?11,?11-?diphenyl-
|
2412522-09-7
|
C29H19Cl
|
|
(3aS,8aR)-2-(5-(trifluoromethyl)pyridin-2-yl)-8,8a-dihydro-3aH-indeno[1,2-d]oxazole
|
2412578-71-1
|
C16H11F3N2O
|
|
2-Thiophenecarboxaldehyde, 5-[2,5-bis(2-butyloctyl)-2,3,5,6-tetrahydro-3,6-dioxo-4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-thienyl]pyrrolo[3,4-c]pyrrol-1-yl]-
|
2412648-26-9
|
C45H67BN2O5S2
|
|
Thieno[3,2-b]thiophene-3-carboxylic acid, 2-(trimethylstannyl)-, ethyl ester
|
2412678-09-0
|
C12H16O2S2Sn
|
|
Pyridine, 3-bromo-5-(cyclopropylmethyl)-
|
2412764-80-6
|
C9H10BrN
|
|
1-bicyclo[1.1.1]pentanylboronic acid
|
2412765-14-9
|
C5H9BO2
|
|
(R)-3-Amino-1-methyl-pyrrolidin-2-one tosylate
|
2412809-21-1
|
C12H18N2O4S
|
|
IDIC-2F
|
2412911-52-3
|
|
|
Sugammadex Impurity 52
|
2412952-88-4
|
C73H114O48S8
|
|
Sugammadex Impurity 21
|
2412952-93-1
|
C72H113NaO48S8
|
|
Sugammadex Impurity 22
|
2412952-94-2
|
C72H113NaO48S8
|
|
Org49095
|
2412952-95-3
|
C71H111NaO48S8
|
|
Org198786-1
|
2412952-96-4
|
C71H114NNaO46S7
|
|
Sugammadex Impurity 16
|
2412952-97-5
|
C69H108BrNaO46S7
|
|
Sugammadex Impurity 26(Org199129-1)
|
2412953-06-9
|
|
|
Mono Oxidation Sugammadex(Org198958-2)
|
2412953-13-8
|
C72H113NaO49S8
|
|
Mono Oxidation Sugammadex(Org199425-1)
|
2412953-14-9
|
C72H113NaO49S8
|
|
SARS-CoV-2-IN-1
|
2412965-59-2
|
C31H39N5O7
|
|
7H-Pyrrolo[2,3-c]pyridin-7-one, 4-bromo-1,6-dihydro-1,6-dimethyl-
|
2412985-61-4
|
C9H9BrN2O
|
|
5'-(4-(hydrazinecarbonyl)-3-propoxyphenyl)-3,3''-dipropoxy-[1,1':3',1''-terphenyl]-4,4''-dicarbohydrazide
|
2413016-98-3
|
C36H42N6O6
|
|
4,4'-(ethyne-1,2-diyl)bis(2-propoxybenzohydrazide)
|
2413016-99-4
|
C22H26N4O4
|
|
1,4-Benzenedicarboxylic acid, 2,5-bis(phenylmethoxy)-, 1,4-dihydrazide
|
2413017-02-2
|
C22H22N4O4
|
|
(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}(methyl)amino)-3-(1-methyl-1H-indol-3-yl)propanoic acid
|
2413047-17-1
|
C28H26N2O4
|
|
3-Azabicyclo[3.1.0]hexane-2,3-dicarboxylic acid, 6,6-dimethyl-, 3-(9H-fluoren-9-ylmethyl) ester, (1R,2S,5S)-
|
2413059-77-3
|
C23H23NO4
|
|
1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-3-(1-ethylpropoxy)-5-[2-formyl-5-(hydroxymethyl)-1H-pyrrol-1-yl]-, ethyl ester, (3R,4R,5S)-
|
2413185-87-0
|
C22H32N2O6
|
|
Oseltamivir Impurity 17
|
2413185-88-1
|
C14H22O4
|
|
(1R,5S,6R)-Ethyl 5-(Pentan-3-yloxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylate
|
2413185-89-2
|
C14H22O4
|
|
Oseltamivir Diastereomer III HCl
|
2413185-95-0
|
C16H28N2O4
|
|
1-Cyclohexene-1-carboxylic acid, 4-[acetyl(1,1-dimethylethyl)amino]-5-(di-2-propen-1-ylamino)-3-(1-ethylpropoxy)-, ethyl ester, (3R,4R,5R)-
|
2413185-96-1
|
C26H44N2O4
|
|
Afatinib Impurity 6
|
2413212-07-2
|
C18H17FN4O2
|
|
Afatinib Impurity N-Oxide
|
2413212-11-8
|
C24H25ClFN5O4
|
|
2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(methylamino)-, (2E)-
|
2413212-13-0
|
C23H23ClFN5O3
|
|
Afatinib Impurity 9
|
2413212-17-4
|
C22H20ClFN4O3
|
|
Afatinib Impurity 18
|
2413212-25-4
|
C24H26FN5O3
|
|
Heptanedioic acid, 2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-, 7-(2-propen-1-yl) ester, (2S)-
|
2413233-46-0
|
C25H27NO6
|
|
1H-Pyrazole-4-carboxamide, 5-amino-N-[[4-[[(3-cyclohexylpropyl)amino]carbonyl]phenyl]methyl]-1-phenyl-
|
2413286-32-3
|
C27H33N5O2
|
|
4,4',4'',4'''-([2,2'-bi(1,3-dithiolylidene)]-4,4',5,5'-tetrayl)tetraaniline
|
2413296-69-0
|
C30H24N4S4
|
|
Apixaban Impurity TTQ
|
2413365-22-5
|
C20H23N3O3
|
|
Fmoc-Lys-OtBu.HCl
|
2413365-23-6
|
C25H33ClN2O4
|
|
D-Lysine, N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-, 1,1-dimethylethyl ester, hydrochloride (1:1)
|
2413365-27-0
|
C25H33ClN2O4
|
|
2-Piperidinecarboxylic acid, 5-[(phenylmethoxy)amino]-, ethyl ester, ethanedioate (1:1), (2R,5S)-
|
2413365-40-7
|
C15H22N2O3.C2H2O4
|
|
1,4-Benzenedicarboxylic acid, 2,5-bis[(4-butyldecyl)oxy]-, 1,4-dihydrazide
|
2413366-64-8
|
C36H66N4O4
|
|
1,4-Benzenedicarboxylic acid, 2,5-bis(3-methylbutoxy)-, 1,4-dihydrazide
|
2413366-66-0
|
C18H30N4O4
|
|
3,6,9,12,15,18,21,24,27,30,33,36-Dodecaoxaheptatriacontane-1-thiol
|
2413368-61-1
|
C25H52O12S
|
|
Mc-GGFG-OH
|
2413428-36-9
|
C25H31N5O8
|
|
N3-Ethyl pseudouridine
|
2413585-37-0
|
C11H16N2O6
|
|
Benzamide, 5-fluoro-2-methoxy-N-[[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl]-
|
2413660-30-5
|
C21H25BFNO4
|
|
Meplazumab
|
2413715-21-4
|
|
|
TCMDC-135051
|
2413716-15-9
|
C29H33N3O3
|